Nasal polyps affect approximately 1-4% of the general population worldwide, with higher rates among those with chronic rhinosinusitis, according to the National Institutes of Health. These soft, noncancerous growths develop in the lining of the nasal passages and sinuses, disrupting normal breathing and smell. Because symptoms often develop slowly, many cases remain undiagnosed until the polyps have already caused significant discomfort. This delay in detection makes effective management of this chronic condition particularly challenging for patients and healthcare professionals alike.
Health
18. Oral Corticosteroids Oral corticosteroids, such as prednisone, are sometimes prescribed for short-term use in patients with severe or rapidly worsening nasal polyps, or when symptoms…